Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ingrid Anna Gause-Nilsson"'
Autor:
Thomas A Zelniker, Jamie P. Dwyer, Avivit Cahn, Stephen D. Wiviott, Itamar Raz, Hiddo J.L. Heerspink, Anna Maria Langkilde, Ofri Mosenzon, Marc S. Sabatine, Ingrid Anna Gause-Nilsson
Publikováno v:
Diabetes. 68
Background: DECLARE-TIMI 58 showed that dapagliflozin (dapa) a sodium glucose co-transporter 2 inhibitor (SGLT2i), reduced the rate of cardiovascular death or hospitalization for heart failure in patients with T2DM with or at high risk of atheroscler
Autor:
Philip Christopher McEwan, H Bennett, Bernt Kartman, Christopher Edmonds, Ingrid Anna Gause-Nilsson
Publikováno v:
Diabetes. 68
Chronic kidney disease (CKD) and end stage renal disease (ESRD) pose a significant global health burden. Approximately 40% of people with type 2 diabetes develop CKD. The Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 trial showed a
1213-P: Assessing the Performance of Cardiovascular Risk Equations in the DECLARE-TIMI 58 Population
Autor:
Christopher Edmonds, Volker Foos, Philip Christopher McEwan, H Bennett, Bernt Kartman, Ingrid Anna Gause-Nilsson
Publikováno v:
Diabetes. 68
Sodium-glucose co-transporter inhibitors have demonstrated reduced incidence of cardiovascular (CV) events, which cannot be fully explained by effects on HbA1c, body weight or blood pressure. Type 2 diabetes mellitus (T2DM) economic models link treat
Autor:
Ingrid Anna Gause-Nilsson, H Bennett, Bernt Kartman, Volker Foos, Philip Christopher McEwan, Christopher Edmonds
Publikováno v:
Diabetes. 68
Risk equations (RE) from the UK Prospective Diabetes Study (UKPDS) remain the most commonly used within economic models of type 2 diabetes mellitus (T2DM). However, clinical practice has evolved since UKPDS reported and the applicability of these RE
Autor:
Darren K. McGuire, Erica L. Goodrich, Marc S. Sabatine, Stephen D. Wiviott, Deepak L. Bhatt, Jamie P. Dwyer, Anna Maria Langkilde, Ofri Mosenzon, Thomas A Zelniker, Itamar Raz, Peter Johansson, Ingrid Anna Gause-Nilsson, Aliza Rozenberg, John P.H. Wilding, Hiddo J.L. Heerspink, Martin Fredriksson, Lawrence A. Leiter, Ilan Yanuv, Avivit Cahn
Publikováno v:
Diabetes. 68
Background: Sodium-glucose co-transporter-2 inhibitors were previously shown to improve renal parameters. In this predefined analysis of DECLARE-TIMI 58, we report the effects of dapagliflozin (dapa) on albuminuria in a broad population of patients w
Autor:
Stephen D. Wiviott, Ofri Mosenzon, Avivit Cahn, Darren McGuire, Marc S. Sabatine, Sabina A. Murphy, Deepak L. Bhatt, John P.H. Wilding, Jindřich Špinar, Rafael Diaz, Assen Goudev, Ingrid Anna Gause-Nilsson, Julia F Kuder, Kazuma Oyama, Lawrence Leiter, Kyong-Soo Park, Itamar Raz
Publikováno v:
Journal of the American College of Cardiology. 75:660
In DECLARE-TIMI 58 (Dapagliflozin Effect on Cardiovascular Events-Thrombolysis in Myocardial Infarction 58), dapagliflozin reduced the risk of the composite of cardiovascular death (CVD) or hospitalization for heart failure (HHF) and of adverse renal
Autor:
Itamar Raz, Marc P. Bonaca, Stephen D. Wiviott, Lawrence Leiter, Deepak L. Bhatt, Ingrid Anna Gause-Nilsson, Ofri Mosenzon, Julia F Kuder, Avivit Cahn, Thomas A Zelniker, Christian T. Ruff, Remo H.M. Furtado, John P.H. Wilding, Sabina A. Murphy, Martin Fredriksson, Anna Maria Langkilde, Darren McGuire, Marc S. Sabatine
Publikováno v:
Journal of the American College of Cardiology. 73:1
The aim of this study was to elucidate protein-protein interactions between tegument proteins of herpes simplex virus type 1 (HSV-1). To do so, we have cloned and expressed in the LexA yeast (Saccharomyces cerevisiae) two-hybrid system, 13 of the 21